Table 2

Baseline Characteristics of Enrolled Participants (N = 25)

Participant Characteristic

n

Mean

%


Years of age

46.4

Male gender

24

96

Race/ethnicity

Caucasian

17

68

African American

4

16

Latino

4

16

Years HIV-infected

13.7

CD4 cell count

494/mm3

HIV RNA < 75 copies/mL

19

76

Months on HAART

82.3

Target dyslipidemia-inducing agents

lopinavir/ritonavir

15

60

atazanavir/ritonavir

3

12

tipranavir/ritonavir

1

4

fosamprenavir/ritonavir

1

4

efavirenz

5

20

Months on target agent

19.0

History of opportunistic infection

13

52

Cardiac risk factors

Lipodystrophy

13

52

hypertension

7

28

family history of hypertension

9

36

family history of hyperlipidemia

11

44

tobacco smokers

8

32

former smokers

7

28

alcohol users

15

60

former alcohol users

5

20

illicit substance users

14

56

former illicit substance users

7

28

Prior antihyperlipidemic use:

9

36


Abrams et al. BMC Complementary and Alternative Medicine 2011 11:60   doi:10.1186/1472-6882-11-60

Open Data